Assembly Biosciences (ASMB) Stock Highlights

15.21 | -3.8%

2024-12-21 06:50:05

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The companys HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Statistics

Range Today

15 16.26

Volume Today 30.7K

Range 1 Year

9 19.93

Volume 1 Year 6.38M

Range 3 Year

7.68 29.4

Volume 3 Year 28.51M

Range 10 Year

7.68 808.32

Volume 10 Year 77.78M

Highlights

Market Capitalization 106.48M (small)

Floating Shares 3.83M

Current Price 15.21

Price To Earnings -1.97

Price To Revenue 0.17

Price To Book 2.24

Earnings Per Share -8.69

Payout Ratio 0%

Performance

Latest -3.8%

1 Month -0.85%

3 Months -20.78%

6 Months +0.6%

1 Year +66.78%

3 Years -43.16%

5 Years -93.94%

10 Years -81.63%

Benchmarks

Market Capitalization

281 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

181 / 368

Free Cashflow

197 / 352

Performance 5 years

297 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.